Akihiro Nishiyama

6PUBLICATIONS
21CO-AUTHORS
Solid tumoursGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 25, 2026
Primary Bronchial Hybrid Low-Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma With EWSR1::CREB3L1 Fusion: Diagnostic Insights From a Challenging Case in the Respiratory Tract.

|Oct 25, 2024
Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.

Akihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi

|Sep 28, 2022
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.

Akihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa

|Apr 01, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cells.

Chiaki Suzuki, Akihiro Nishiyama, Sachiko Arai

|Jun 19, 2021
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.

Koji Fukuda, Sakiko Otani, Shinji Takeuchi

|Aug 01, 2020
MET amplification results in heterogeneous responses to osimertinib in EGFR-mutant lung cancer treated with erlotinib.

Akihiro Nishiyama, Shinji Takeuchi, Yuta Adachi

Pageof 1

Frequent Collaborators

5 joint publications

Seiji Yano

2 joint publications

Koji Fukuda

2 joint publications

Atsushi Tajima

2 joint publications

Hiroshi Kotani